marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Sarepta Therapeutics Financial Ratios 2011-2024 | SRPT
Annual Financial Ratios Sarepta Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-23.8 | -15.1 | -14.9 | -12.2 | -12.1 | -23.8 | -75.1 | -5.3 | -2.3 | -3.5 | -7.6 | -5.3 | -50.3 |
P/S |
10.3 | 11.4 | 8.9 | 12.6 | 22.8 | 28.6 | 24.6 | 260.2 | 401.0 | 49.2 | 59.5 | 17.2 | 2.5 |
EPS |
-5.8 | -8.0 | -5.2 | -7.1 | -9.7 | -5.5 | -0.9 | -5.5 | -5.2 | -3.4 | -3.3 | -5.1 | -0.0 |
EV (Enterprise Value) |
14.8 B | 12.4 B | 6.33 B | 7.51 B | 8.84 B | 8.85 B | 3.73 B | 1.38 B | 506 M | 454 M | 634 M | 534 M | 100 M |
EBITDA per Share |
-2.42 | -5.65 | -5.19 | -6.89 | -7.08 | -5.21 | -2.37 | -5.31 | -5.08 | -3.25 | -2.63 | -1.19 | -1.6 |
EV/EBITDA |
-14.9 | -11.6 | -16.3 | -25.1 | -26.1 | -5.0 | -2.1 | -3.2 | -6.6 | -16.1 | -2.3 | ||
PEG |
3.0 | -0.55 | -1.02 | -0.6 | 0.16 | 0.04 | -0.89 | 0.95 | 0.04 | 1.46 | -0.21 | 0.0 | -0.54 |
P/B |
14.9 | 27.6 | 6.7 | 8.9 | 10.6 | 8.3 | 4.8 | 4.2 | 2.6 | 1.9 | 3.4 | 5.2 | 3.8 |
P/CF |
-25.5 | -32.7 | -14.0 | 63.2 | -16.7 | -19.0 | -15.0 | -5.6 | -3.3 | -3.1 | -12.4 | -20.8 | -4.5 |
ROE % |
-62.37 | -182.75 | -45.13 | -72.74 | -87.40 | -35.06 | -6.42 | -79.38 | -115.59 | -54.83 | -45.30 | -98.07 | -7.47 |
ROA % |
-16.42 | -22.49 | -13.30 | -18.57 | -39.23 | -22.04 | -3.88 | -63.02 | -80.37 | -46.03 | -38.41 | -59.17 | -4.26 |
ROCE % |
-31.17 | -139.29 | -49.54 | -74.06 | -33.52 | -23.55 | -11.51 | -75.77 | -104.11 | -51.82 | -35.32 | -23.55 | -106.40 |
Current Ratio |
1.4 | 1.1 | 1.4 | 1.3 | 5.5 | 8.2 | 13.9 | 5.0 | 3.6 | 6.7 | 7.5 | 2.5 | 2.2 |
DSO |
90.3 | 71.9 | 66.1 | 65.0 | 90.0 | 59.5 | 69.6 | 352.0 | 1158.5 | 90.4 | 90.6 | 46.1 | 28.2 |
DIO |
- | - | - | - | 1105.5 | 1339.1 | 4150.1 | 35975.0 | - | - | - | - | - |
DPO |
- | - | - | - | 439.2 | 361.1 | 420.3 | 83360.4 | - | - | - | - | - |
Operating Cycle |
90.3 | 71.9 | 66.1 | 65.0 | 1195.5 | 1398.6 | 4219.7 | 36327.0 | - | - | - | - | - |
Cash Conversion Cycle |
90.3 | 71.9 | 66.1 | 65.0 | 756.3 | 1037.4 | 3799.4 | -47033.4 | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sarepta Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.35 | 0.07 | 0.38 | - | -0.46 | -0.27 | -5.86 | - | -2.94 | -2.65 | -1.2 | - | -0.6 | -1.02 | -2.1 | -2.4 | -2.5 | -1.93 | -0.23 | -3.16 | -1.7 | -3.74 | -1.07 | -2.05 | -1.15 | -1.67 | -0.55 | -0.37 | -0.78 | -1.15 | 1.53 | -1.62 | -1.18 | -1.35 | -1.31 | -1.44 | -1.25 | -1.01 | -1.49 | -1.08 | -0.71 | -0.85 | -0.75 | -0.23 | -1.24 | -0.6 | -1.32 | -2.36 | -2.17 | 0.36 | -0.78 | -0.06 | -0.18 | 0.06 | 0.02 |
EBITDA per Share |
0.24 | - | 0.46 | - | -0.23 | -1.5 | -1.44 | - | -1.5 | -2.41 | -0.87 | - | -82.5 | -2.1 | -1.8 K | -2.16 K | -1.5 K | -1.61 | -1.46 | -3.09 K | -1.43 | -3.57 | -1 | -2.03 K | -0.93 | -1.5 | -0.44 | -0.36 | -0.65 | -1.09 | -0.69 | -1.62 | -1.09 | -1.28 | -1.28 | -1.44 | -1.15 | -0.96 | -1.47 | -1.08 | -0.76 | -0.72 | -0.65 | -0.87 | -0.71 | -0.51 | -0.47 | -0.39 | -0.25 | -0.21 | -0.29 | -0.4 | -0.46 | -0.43 | -0.28 |
ROE % |
1.75 | -6.35 | -10.18 | -81.09 | -140.91 | -195.38 | -224.01 | -103.94 | -114.20 | -64.63 | -49.54 | -58.27 | -83.12 | -98.66 | -101.68 | -72.74 | -76.70 | -66.34 | -80.33 | -87.40 | -72.24 | -64.20 | -41.00 | -35.06 | -24.45 | -23.10 | -20.50 | -6.42 | -29.65 | -40.46 | -50.97 | -79.38 | -87.09 | -97.52 | -101.01 | -115.59 | -99.55 | -84.06 | -75.75 | -54.83 | -40.46 | -45.67 | -39.69 | -45.30 | -91.92 | -114.98 | -100.78 | -98.07 | -52.43 | -25.32 | -27.70 | -7.47 | -12.96 | 4.12 | 5.91 |
ROA % |
0.93 | -1.32 | -2.28 | -18.97 | -27.14 | -33.99 | -36.66 | -15.04 | -16.85 | -7.05 | -10.00 | -10.81 | -17.15 | -21.93 | -24.03 | -18.57 | -25.15 | -25.50 | -35.61 | -39.23 | -34.88 | -32.60 | -24.09 | -22.04 | -15.29 | -14.29 | -12.46 | -3.88 | -22.90 | -32.63 | -42.50 | -63.02 | -65.79 | -71.38 | -71.98 | -80.37 | -71.80 | -62.73 | -58.93 | -46.03 | -34.00 | -38.50 | -33.56 | -38.41 | -65.66 | -75.42 | -64.96 | -59.17 | -31.48 | -14.70 | -16.27 | -4.26 | -7.39 | 2.35 | 3.37 |
ROCE % |
- | - | - | - | -30.49 | -60.98 | -90.04 | -69.69 | -77.03 | -53.88 | -59.36 | -70.24 | -92.66 | -103.31 | -86.93 | -74.06 | -79.79 | -76.90 | -92.39 | -86.23 | -71.60 | -63.28 | -39.65 | -33.29 | -22.72 | -21.75 | -19.75 | -21.75 | -45.07 | -56.04 | -66.46 | -79.22 | -86.83 | -97.23 | -100.91 | -115.68 | -99.87 | -86.28 | -76.38 | -54.02 | -49.25 | -45.55 | -40.22 | -36.29 | -31.33 | -26.99 | -24.56 | -23.87 | -43.65 | -73.32 | -100.48 | -112.24 | -35.21 | -31.63 | -17.28 |
Current Ratio |
1.5 | 1.5 | 1.4 | 1.4 | 1.3 | 1.3 | 1.3 | 1.1 | 1.2 | - | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.8 | 1.8 | 1.8 | 1.8 | 2.7 | 2.7 | 2.7 | 2.7 | 2.5 | 2.5 | 2.5 | 2.5 | 4.8 | 4.8 | 4.8 | 4.8 | 3.3 | 3.3 | 3.3 | 3.3 | 6.2 | 6.2 | 6.2 | 6.2 | 6.6 | 6.6 | 6.6 | 6.6 | 2.5 | 2.5 | 2.5 | 2.5 | - | - | - | - |
DSO |
77.6 | 92.9 | 86.0 | - | 76.4 | 80.5 | 78.9 | - | 39.9 | 34.8 | 71.7 | - | 66.8 | 68.3 | 68.2 | 63.7 | 64.2 | 67.3 | 77.2 | 82.8 | 83.7 | 87.6 | 73.4 | 53.0 | 57.0 | 60.9 | 55.5 | 47.0 | 58.5 | 76.8 | 96.9 | 88.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
77.6 | 92.9 | 86.0 | - | 76.4 | 80.5 | 78.9 | - | 39.9 | 34.8 | 71.7 | - | 66.8 | 68.3 | 68.2 | 63.7 | 64.2 | 67.3 | 77.2 | 82.8 | 83.7 | 87.6 | 73.4 | 53.0 | 57.0 | 60.9 | 55.5 | 47.0 | 58.5 | 76.8 | 96.9 | 88.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
77.6 | 92.9 | 86.0 | - | 76.4 | 80.5 | 78.9 | - | 39.9 | 34.8 | 71.7 | - | 66.8 | 68.3 | 68.2 | 63.7 | 64.2 | 67.3 | 77.2 | 82.8 | 83.7 | 87.6 | 73.4 | 53.0 | 57.0 | 60.9 | 55.5 | 47.0 | 58.5 | 76.8 | 96.9 | 88.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency